A detailed history of Black Rock Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Black Rock Inc. holds 838,000 shares of AZN stock, worth $65.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
838,000
Previous 6,528,828 87.16%
Holding current value
$65.4 Million
Previous $440 Million 87.09%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$61.03 - $69.57 $12.2 Million - $13.9 Million
199,642 Added 3.06%
6,728,470 $456 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $10.9 Million - $12.2 Million
175,470 Added 2.76%
6,528,828 $440 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $2.53 Million - $2.8 Million
39,033 Added 0.62%
6,353,358 $430 Million
Q2 2023

Aug 11, 2023

SELL
$69.91 - $75.81 $192 Million - $208 Million
-2,743,920 Reduced 30.29%
6,314,325 $452 Million
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $192 Million - $218 Million
-3,047,414 Reduced 25.17%
9,058,245 $629 Million
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $57.5 Million - $74.8 Million
1,061,344 Added 9.61%
12,105,659 $821 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $47.4 Million - $121 Million
-893,983 Reduced 7.49%
11,044,315 $606 Million
Q2 2022

Aug 12, 2022

BUY
$59.26 - $71.14 $265 Million - $318 Million
4,471,806 Added 59.89%
11,938,298 $789 Million
Q1 2022

May 12, 2022

BUY
$55.72 - $67.12 $74.9 Million - $90.2 Million
1,343,939 Added 21.95%
7,466,492 $495 Million
Q4 2021

Feb 10, 2022

SELL
$54.02 - $63.83 $118 Million - $139 Million
-2,185,440 Reduced 26.31%
6,122,553 $357 Million
Q3 2021

Nov 09, 2021

BUY
$55.56 - $60.79 $7.4 Million - $8.1 Million
133,244 Added 1.63%
8,307,993 $499 Million
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $396 Million - $492 Million
8,174,749 New
8,174,749 $490 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.